SpyGlass Pharma, Inc. SGP
Set alert
32.24 USD -0.27 -0.83%
At close
32.24 0.00 0.00%
Pre-market · Nov 2, 8:24 AM ET
31.75 Day range 32.93
17.06 52-week range 33.84
- YTD
- +22.12%
- 1 year
- +22.12%
- Open
- 32.21
- Prev close
- 32.51
- Mkt cap
- 1.08B
- Vol
- 94.15K
- Avg vol
- 102.20K
- EPS
- -2.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 31.75
- High
- 32.93
- Forward P/E
- -11.46
- Beta
- 0.00
- Short ratio
- 9.43
- Inst. own
- 94.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 27.11
- 200-d avg
- 24.32
- 1y target
- 44.00
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -21.1×
FY 2025 5y median -21.1× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.5×
FY 2025 5y median -8.5× FY 2025
P/FCF -25.2×
FY 2025 5y median -25.2× FY 2025
EV/EBITDA -19.0×
FY 2025 5y median -19.0× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -4.0%
FY 2025 5y median -4.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 40.3%
FY 2025 5y median 40.3% FY 2025
ROIC -38.6%
FY 2025 5y median -38.6% FY 2025
ROA -34.4%
FY 2025 5y median -34.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 12.7×
FY 2025 5y median 12.7× FY 2025
Quick Ratio 12.7×
FY 2025 5y median 12.7× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 2.4×
FY 2025 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31